Cargando…

Incomplete removal of basal cell carcinoma: what is the value of further surgery?

INTRODUCTION: Surgical management of skin cancer is an important part of modern maxillofacial surgery. The common tumours treated are squamous cell carcinoma, malignant melanoma and some benign lesions, but the largest group of tumours are the basal cell carcinomas. Although only locally aggressive,...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Shiralee S., Cliff, Sandeep H., Ward Booth, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661037/
https://www.ncbi.nlm.nih.gov/pubmed/22868984
http://dx.doi.org/10.1007/s10006-012-0348-3
_version_ 1782270619691253760
author Patel, Shiralee S.
Cliff, Sandeep H.
Ward Booth, Peter
author_facet Patel, Shiralee S.
Cliff, Sandeep H.
Ward Booth, Peter
author_sort Patel, Shiralee S.
collection PubMed
description INTRODUCTION: Surgical management of skin cancer is an important part of modern maxillofacial surgery. The common tumours treated are squamous cell carcinoma, malignant melanoma and some benign lesions, but the largest group of tumours are the basal cell carcinomas. Although only locally aggressive, if they are not completely removed, recurrence may occur and be troublesome, especially in the head and neck. Even in this region, incomplete excision is uncommon, less than 20 %, but management of positive margins remains controversial. This review evaluates the effectiveness of a further surgical intervention after a positive margin. MATERIALS AND METHODS: A retrospective audit was undertaken to determine the rate of positive margins within the unit and subsequently the percentage of residual tumour found in any secondary excisions. RESULTS: The results show that in a sample of 247 patients, 11 % had positive peripheral margins. A second excision only showed that 36 % had any evidence of residual tumour. DISCUSSION: The study raises the question of the value of further surgery. Finally, the authors suggest a more focused approach to the finding of a positive margin before the patient is offered more treatment.
format Online
Article
Text
id pubmed-3661037
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-36610372013-05-22 Incomplete removal of basal cell carcinoma: what is the value of further surgery? Patel, Shiralee S. Cliff, Sandeep H. Ward Booth, Peter Oral Maxillofac Surg Original Article INTRODUCTION: Surgical management of skin cancer is an important part of modern maxillofacial surgery. The common tumours treated are squamous cell carcinoma, malignant melanoma and some benign lesions, but the largest group of tumours are the basal cell carcinomas. Although only locally aggressive, if they are not completely removed, recurrence may occur and be troublesome, especially in the head and neck. Even in this region, incomplete excision is uncommon, less than 20 %, but management of positive margins remains controversial. This review evaluates the effectiveness of a further surgical intervention after a positive margin. MATERIALS AND METHODS: A retrospective audit was undertaken to determine the rate of positive margins within the unit and subsequently the percentage of residual tumour found in any secondary excisions. RESULTS: The results show that in a sample of 247 patients, 11 % had positive peripheral margins. A second excision only showed that 36 % had any evidence of residual tumour. DISCUSSION: The study raises the question of the value of further surgery. Finally, the authors suggest a more focused approach to the finding of a positive margin before the patient is offered more treatment. Springer-Verlag 2012-08-07 2013 /pmc/articles/PMC3661037/ /pubmed/22868984 http://dx.doi.org/10.1007/s10006-012-0348-3 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Article
Patel, Shiralee S.
Cliff, Sandeep H.
Ward Booth, Peter
Incomplete removal of basal cell carcinoma: what is the value of further surgery?
title Incomplete removal of basal cell carcinoma: what is the value of further surgery?
title_full Incomplete removal of basal cell carcinoma: what is the value of further surgery?
title_fullStr Incomplete removal of basal cell carcinoma: what is the value of further surgery?
title_full_unstemmed Incomplete removal of basal cell carcinoma: what is the value of further surgery?
title_short Incomplete removal of basal cell carcinoma: what is the value of further surgery?
title_sort incomplete removal of basal cell carcinoma: what is the value of further surgery?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661037/
https://www.ncbi.nlm.nih.gov/pubmed/22868984
http://dx.doi.org/10.1007/s10006-012-0348-3
work_keys_str_mv AT patelshiralees incompleteremovalofbasalcellcarcinomawhatisthevalueoffurthersurgery
AT cliffsandeeph incompleteremovalofbasalcellcarcinomawhatisthevalueoffurthersurgery
AT wardboothpeter incompleteremovalofbasalcellcarcinomawhatisthevalueoffurthersurgery